Related Experiment Videos
Adenosine deaminase (ADA) overproduction associated with congenital hemolytic anemia: case report and molecular
Abstract:
We report the fourth case of adenosine deaminase (ADA) overproduction associated with hereditary nonspherocytic hemolytic anemia and the molecular analysis of this anomaly. The proband was a 10-year-old Japanese boy, who had an episode of erythroblastosis fetalis during the perinatal period. The red cell ADA activity showed a 110-fold increase and the red cell ATP level was about 64% of the comparably reticulocyte-rich controls, but the lymphocyte ADA activity was within the normal range. Western blotting of partially purified ADA from red cells revealed an increased amount of enzyme in the patient's red cells. No gene amplification or gene rearrangement was found by Southern blot analysis, and no increase of ADA mRNA in reticulocyte RNA was detected by dot blot analysis using ADA cDNA. We constructed a genomic DNA library and obtained three clones containing the 5'-promoter region of ADA gene. The 2.2 kb ADA promoter DNA fragment of these clones was fused to the chloramphenicol acetyl transferase (CAT) gene, and transfected to human erythroid cell line K562, and assayed for CAT activity. One of the clones, pADOP 2 cat, expressed about 2.6 times higher CAT activity than the normal ADA promoter fused to CAT gene in K562, but such enhancement was not seen in human non-erythroid cell lines; HL 60 and Raji. From these results, it is most likely, though not conclusive, that the 5' promotor fragment of the ADA gene of the patient was responsible for the cell-specific enhancement of protein synthesis.
Insights
This study details a rare case of adenosine deaminase (ADA) overproduction causing hereditary nonspherocytic hemolytic anemia. Molecular analysis suggests a patient-specific ADA gene promoter region enhances enzyme synthesis in red blood cells.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Background:
- Hereditary nonspherocytic hemolytic anemia (HNSHA) is a group of rare blood disorders.
- Adenosine deaminase (ADA) is a crucial enzyme in purine metabolism, essential for lymphocyte function.
- Overproduction of ADA is exceptionally rare and its molecular basis is poorly understood.
Observation:
- A 10-year-old Japanese boy presented with HNSHA and a 110-fold increase in red blood cell ADA activity, while lymphocyte ADA activity remained normal.
- Western blot analysis confirmed increased ADA enzyme levels in the patient's red blood cells.
- No gene amplification, rearrangement, or increased ADA mRNA levels were detected, ruling out common genetic alterations.
Findings:
- Functional analysis using a reporter gene assay revealed that a specific 5' promoter fragment of the patient's ADA gene significantly enhanced gene expression in erythroid cell lines (K562).
- This enhanced expression was cell-specific, as it was not observed in non-erythroid cell lines (HL-60, Raji).
- These findings implicate a mutation in the ADA gene promoter as the cause of erythroid-specific ADA overproduction.
Implications:
- This research identifies a novel molecular mechanism for ADA overproduction, specifically a promoter-driven anomaly.
- Understanding this mechanism could lead to targeted therapies for rare hemolytic anemias.
- The study highlights the importance of investigating promoter regions in genetic disorders with unusual enzyme activity patterns.